Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-10,814
Closed -$3.48M 223
2018
Q2
$3.48M Buy
+10,814
New +$3.38M 0.54% 53
2017
Q2
Sell
-2,076
Closed -$379K 611
2017
Q1
$379K Sell
2,076
-1,166
-36% -$203K 0.02% 703
2016
Q4
$520K Sell
3,242
-1,056
-25% -$155K 0.03% 569
2016
Q3
$606K Buy
4,298
+897
+26% +$125K 0.03% 629
2016
Q2
$464K Buy
+3,401
New +$451K 0.02% 655

Other funds holding CHE

Clinton Group's CHE Position: Q3 2018 in Review

Clinton Group sold out of Chemed (CHE) in Q3 2018, closing a stake of 10,814 shares — an estimated $3.48M sold.

Clinton Group first reported a position in CHE in Q2 2016 and held it in 5 quarters. The position peaked at $3.48M in Q2 2018. 352 funds tracked by Wall St. Rank hold CHE as of Q3 2018.

  • Clinton Group reported no remaining Chemed position as of Q3 2018 after selling out during the quarter.
  • Clinton Group sold 10,814 Chemed shares in Q3 2018, an estimated $3.48M.
  • Clinton Group first reported a position in Chemed in Q2 2016 and held it in 5 quarters.
  • Clinton Group's Chemed position peaked at $3.48M in Q2 2018.
  • 352 funds tracked by Wall St. Rank held Chemed as of Q3 2018.

Based on Clinton Group's 13F filing for Q3 2018, filed 10 Oct 2018.